STOCK TITAN
  1. Home
  2. Sec-filings
  3. SLNO
  4. [8-K] – SOLENO THERAPEUTICS INC (SLNO) (CIK 0001484565)

[8-K] – SOLENO THERAPEUTICS INC (SLNO) (CIK 0001484565)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock SLNO logo
Soleno Therapeutics Inc

NASDAQ:SLNO

SLNO Rankings

#1650 Ranked by Market Cap
N/A Ranked by Dividends

SLNO Latest News

Oct 13, 2025
Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors
Aug 27, 2025
Soleno Therapeutics to Participate in Upcoming September Conferences
Aug 6, 2025
Soleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports Second Quarter 2025 Financial Results
Jul 28, 2025
Soleno Therapeutics to Report Second Quarter 2025 Financial Results on August 6, 2025, at 4:30 PM ET
Jul 10, 2025
Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock

SLNO Latest SEC Filings

Sep 10, 2025
[8-K] Soleno Therapeutics, Inc. Reports Material Event
Aug 18, 2025
[8-K] Soleno Therapeutics, Inc. Reports Material Event
Aug 15, 2025
[144] Soleno Therapeutics, Inc. SEC Filing
Aug 14, 2025
[SCHEDULE 13G/A] Soleno Therapeutics, Inc. SEC Filing
Aug 14, 2025
[SCHEDULE 13G/A] Soleno Therapeutics, Inc. SEC Filing

SLNO Stock Data

3.39B
51.75M
1.79%
110.24%
14.27%
Biotechnology
Electromedical & Electrotherapeutic Apparatus
Link
United States
REDWOOD CITY